In a study of familial GBM, it was observed that heterozygous and homozygous SMARCB1 mutations were associated with a diagnosis at a significantly younger age, suggesting that these genetic alterations accelerate tumor progression, promoting cell proliferation through pathways such as PI3K and MAPK [32]. Here, SMARCB1 is linked to glioblastoma.